Literature DB >> 7138790

Erythroblast iron metabolism in sideroblastic marrows.

A May, P de Souza, K Barnes, S Kaaba, A Jacobs.   

Abstract

The uptake of iron by bone marrow erythroblasts and its intracellular distribution have been studied in 23 patients with primary sideroblastic anaemia (SA), five patients with secondary SA and one patient with only non-ringed sideroblasts. EM of erythroblasts from 18 cases showed both mitochondrial iron deposits and cytoplasmic ferritin aggregates in all cases except the patient with only non-ringed sideroblasts. Iron uptake by erythroblasts in whole bone marrow was normal but there was a decreased incorporation into haem and an increased incorporation into cell stroma. Age matching of erythroblasts using Percoll density gradient centrifugation indicated that stromal iron incorporation was high at all stages of erythroblast development even before haem synthesis had become a major metabolic activity and in intermediate and late erythroblasts a real decrease in haem synthesis appeared less certain. These observations, together with the inability to correct the abnormality in vitro with either pyridoxal phosphate or delta amino-laevulinic acid suggest that the primary defect in SA may be an abnormality of mitochondrial iron metabolism rather than an abnormality of haem synthesis.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7138790     DOI: 10.1111/j.1365-2141.1982.tb03937.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Uptake and intracellular distribution of iron from transferrin and chelators in erythroid cells.

Authors:  G J Kontoghiorghes; A May
Journal:  Biol Met       Date:  1990

2.  Sideroblastic colonies in erythroid cultures grown from normal human marrow.

Authors:  S Kaaba; A Jacobs; K Barnes
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

Review 3.  Serum ferritin and malignant tumours.

Authors:  A Jacobs
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

Review 4.  Oxidative stress and the myelodysplastic syndromes.

Authors:  Morag J Farquhar; David T Bowen
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

5.  A family study of congenital X linked sideroblastic anaemia.

Authors:  J Holmes; A May; D Geddes; A Jacobs
Journal:  J Med Genet       Date:  1990-01       Impact factor: 6.318

Review 6.  Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.

Authors:  A Jacobs
Journal:  J Clin Pathol       Date:  1985-11       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.